These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 8446583)

  • 21. Myostatin deficiency partially rescues the bone phenotype of osteogenesis imperfecta model mice.
    Oestreich AK; Carleton SM; Yao X; Gentry BA; Raw CE; Brown M; Pfeiffer FM; Wang Y; Phillips CL
    Osteoporos Int; 2016 Jan; 27(1):161-70. PubMed ID: 26179666
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Osteogenesis imperfecta: comparison of molecular defects with bone histological changes.
    Sztrolovics R; Glorieux FH; Travers R; van der Rest M; Roughley PJ
    Bone; 1994; 15(3):321-8. PubMed ID: 7520724
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Are Changes in Composition in Response to Treatment of a Mouse Model of Osteogenesis Imperfecta Sex-dependent?
    Boskey AL; Marino J; Spevak L; Pleshko N; Doty S; Carter EM; Raggio CL
    Clin Orthop Relat Res; 2015 Aug; 473(8):2587-98. PubMed ID: 25903941
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Altered collagen structure in mouse tail tendon lacking the alpha 2(I) chain.
    McBride DJ; Choe V; Shapiro JR; Brodsky B
    J Mol Biol; 1997 Jul; 270(2):275-84. PubMed ID: 9236128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Osteogenesis imperfecta: cloning of a pro-alpha 2(I) collagen gene with a frameshift mutation.
    Pihlajaniemi T; Dickson LA; Pope FM; Korhonen VR; Nicholls A; Prockop DJ; Myers JC
    J Biol Chem; 1984 Nov; 259(21):12941-4. PubMed ID: 6092353
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dietary fluoride restriction does not alter femoral biomechanical strength in col1a2-deficient (oim) mice with type I collagen glomerulopathy.
    Carleton SM; Whitford GM; Phillips CL
    J Nutr; 2010 Oct; 140(10):1752-6. PubMed ID: 20724489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of mutant alpha (I)-procollagen in osteoblast and fibroblast cultures from a proband with osteogenesis imperfecta type IV.
    Chipman SD; Shapiro JR; McKinstry MB; Stover ML; Branson P; Rowe DW
    J Bone Miner Res; 1992 Jul; 7(7):793-805. PubMed ID: 1642148
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel mild variant of osteogenesis imperfecta type I caused by a Gly1088Glu mutation in COL1A1.
    Xia XY; Li WW; Li N; Wu QY; Cui YX; Li XJ
    Mol Med Rep; 2014 Jun; 9(6):2187-90. PubMed ID: 24682174
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel variant in Sp7/Osx associated with recessive osteogenesis imperfecta with bone fragility and hearing impairment.
    Fiscaletti M; Biggin A; Bennetts B; Wong K; Briody J; Pacey V; Birman C; Munns CF
    Bone; 2018 May; 110():66-75. PubMed ID: 29382611
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transfer of proalpha2(I) cDNA into cells of a murine model of human Osteogenesis Imperfecta restores synthesis of type I collagen comprised of alpha1(I) and alpha2(I) heterotrimers in vitro and in vivo.
    Niyibizi C; Smith P; Mi Z; Phillips CL; Robbins P
    J Cell Biochem; 2001 Jun 26-Jul 25; 83(1):84-91. PubMed ID: 11500956
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Splice site mutation causing deletion of exon 21 sequences from the pro alpha 2(I) chain of type I collagen in a patient with severe dentinogenesis imperfecta but very mild osteogenesis imperfecta.
    Nicholls AC; Oliver J; McCarron S; Winter GB; Pope FM
    Hum Mutat; 1996; 7(3):219-27. PubMed ID: 8829655
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A new mutation in COL1A1 gene in a family with osteogenesis imperfecta].
    Wang Z; Xu DL; Chen Z; Hu JY; Yang Z; Wang LT
    Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(3):170-3. PubMed ID: 16638323
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Osteogenesis imperfecta type VII: an autosomal recessive form of brittle bone disease.
    Ward LM; Rauch F; Travers R; Chabot G; Azouz EM; Lalic L; Roughley PJ; Glorieux FH
    Bone; 2002 Jul; 31(1):12-8. PubMed ID: 12110406
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Homozygosity for CREB3L1 premature stop codon in first case of recessive osteogenesis imperfecta associated with OASIS-deficiency to survive infancy.
    Lindahl K; Åström E; Dragomir A; Symoens S; Coucke P; Larsson S; Paschalis E; Roschger P; Gamsjaeger S; Klaushofer K; Fratzl-Zelman N; Kindmark A
    Bone; 2018 Sep; 114():268-277. PubMed ID: 29936144
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exome sequencing identifies truncating mutations in human SERPINF1 in autosomal-recessive osteogenesis imperfecta.
    Becker J; Semler O; Gilissen C; Li Y; Bolz HJ; Giunta C; Bergmann C; Rohrbach M; Koerber F; Zimmermann K; de Vries P; Wirth B; Schoenau E; Wollnik B; Veltman JA; Hoischen A; Netzer C
    Am J Hum Genet; 2011 Mar; 88(3):362-71. PubMed ID: 21353196
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Age- and genotype-dependence of bone material properties in the osteogenesis imperfecta murine model (oim).
    Grabner B; Landis WJ; Roschger P; Rinnerthaler S; Peterlik H; Klaushofer K; Fratzl P
    Bone; 2001 Nov; 29(5):453-7. PubMed ID: 11704498
    [TBL] [Abstract][Full Text] [Related]  

  • 37. G76E substitution in type I collagen is the first nonlethal glutamic acid substitution in the alpha1(I) chain and alters folding of the N-terminal end of the helix.
    Cabral WA; Chernoff EJ; Marini JC
    Mol Genet Metab; 2001 Apr; 72(4):326-35. PubMed ID: 11286507
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The clinicopathological features of three babies with osteogenesis imperfecta resulting from the substitution of glycine by valine in the pro alpha 1 (I) chain of type I procollagen.
    Cole WG; Patterson E; Bonadio J; Campbell PE; Fortune DW
    J Med Genet; 1992 Feb; 29(2):112-8. PubMed ID: 1613761
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Local amino acid sequence patterns dominate the heterogeneous phenotype for the collagen connective tissue disease Osteogenesis Imperfecta resulting from Gly mutations.
    Xiao J; Yang Z; Sun X; Addabbo R; Baum J
    J Struct Biol; 2015 Oct; 192(1):127-37. PubMed ID: 25980613
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Altered cytoskeletal organization characterized lethal but not surviving Brtl+/- mice: insight on phenotypic variability in osteogenesis imperfecta.
    Bianchi L; Gagliardi A; Maruelli S; Besio R; Landi C; Gioia R; Kozloff KM; Khoury BM; Coucke PJ; Symoens S; Marini JC; Rossi A; Bini L; Forlino A
    Hum Mol Genet; 2015 Nov; 24(21):6118-33. PubMed ID: 26264579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.